Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker ONC
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 3, 2026 | 12779041 EGFR degraders and methods of use | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Oct 6, 2026 | 12752012 EGFR degraders and associated methods of use | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Sep 15, 2026 | 12735423 (R) and (S)-3-(tert-butyl)-N-(1-(4-(6-(6-(4-((1-(4-(2,4-dioxotetrahyd… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Sep 8, 2026 | 12729203 Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK i… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Sep 1, 2026 | 12723048 5-amino-6,8-dihydro-1H-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamid… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Aug 4, 2026 | 12698294 Substituted pyrazoles as sting modulators | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Jul 14, 2026 | 12679844 Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibi… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Jul 7, 2026 | 12673933 Aminopyrazine compounds as HPK1 inhibitor and the use thereof | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Jun 2, 2026 | 12643903 Bifunctional compounds for degradation of EGFR and related methods of… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| May 26, 2026 | 12637480 Heterocyclic compounds as sting modulators | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| May 19, 2026 | 12630552 Inhibitors of KRAS G12C | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Apr 28, 2026 | 12612407 Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Apr 21, 2026 | 12606556 TYK-2 inhibitor | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Mar 31, 2026 | 12590096 Imidazo[2,1-f][1,2,4]triazin-4-amine as TLR8 agonists | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Mar 24, 2026 | 12583866 Pyrido[2,3-b][1,4]oxazines or tetrahydropyrido[2,3-b][1,4]oxazepines… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Jan 13, 2026 | 12521440 Degradation of bruton's tyrosine kinase (BTK) by conjugation of BTK i… | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516053 Bcl-2 inhibitors | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Nov 4, 2025 | 12459958 Tricyclic compounds as HPK1 inhibitor and the use thereof | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
| Oct 28, 2025 | 12454534 Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof | ONC BeOne Medicines Ltd. | utility | Google Patents ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances